¿Sobreutilización de corticoides en las exacerbaciones de pacientes con enfermedad pulmonar obstructiva crónica?

Cristóbal Gallego Muñoz, Luis Olmos Gutiérrez, María Onteniente Candela, Carles Iniesta Navalón

Resumen


-

Palabras clave


-

Texto completo:

PDF / CITATION

Referencias


Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012; 379:1341-51.

Matkovic Z, Huerta A, Soler N, Domingo R, Gabarrús A, Torres A et al. Predictors of adverse outcome in patients hospitalised for exacerbation of COPD. Respiration. 2012; 84:17-26.

Aaron SD, Vandemheen KL, Hebert P, Dales R, Stiell IG, Ahuja J et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med. 2003; 348:2618-25.

Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001; 163: 1256-76.

Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW et al., Department of Veterans Affairs Cooperative Study Group. Effect of systemic glucocorticoids on exacerba-tions of chronic obstructive pulmonary disease. N Engl J Med. 1999; 340:1941-7.

De Jong YP, Uil SM, Grotjohan HP, Postma DS, Kerstjens HAM, van den Berg JWK. Oral or IV prednisolone in the treatment of COPD exacerbations: A randomized, controlled, double-blind study. Chest. 2007; 132:1741-7.

Ding Z, Li X, Lu Y, Rong G, Yang R, Zhang R et al. A randomized, controlled multicentric study of inhaled budesonide and intravenous methylprednisolone in the treatment on acute exa-cerbation of chronic obstructive pulmonary disease. Respir Med. 2016; 121:39-47.

Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA et al. Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Phar-macological treatment of stable chronic obstructive pulmonary disease. Arch Bronconeumol. 2017; 53:324-35.

Pozo-Rodríguez F, López-Campos JL, Álvarez-Martínez CJ, Castro- Acosta A, Agüero R, Hueto J et al. Clinical audit of COPD patients requiring hospital admissions in Spain: AUDIPOC study. PLoS One. 2012; 7:e42156.

Rueda-Camino JA, Bernal-Bello D, Canora-Lebrato J, Velázquez- Ríos L, García de Viedma-García V, Guerrero-Santillán M et al. Dosis altas de corticoides sistémicos en pacientes ingresados por exacerbación de EPOC. Un estudio de cohortes. Rev Clin Esp. 2017 (artículo en prensa).




DOI: https://doi.org/10.19230/jonnpr.2073

Número de visitas del artículo: 92

Número de descargas: 65

Número de descargas: 22

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2018 Journal of Negative and No Positive Results

Incluida in:

BASES DE DATOS Y BUSCADORES

Google Scholar Hinari J-Gate ResearchBib

CATALOGOS DE REVISTAS

Dialnet DOAJ DRJI mEDRA REDIB ROAD

INDICES DE CITAS

Citefactor isindexing MIAR

INICIATIVAS DE ACCESO ABIERTO

Dulcinea SHERPA/ROMEO

Journal of Negative and No Positive Results

Edita: Research and Science S.L.

ISSN-e: 2529-850X

Dep. Legal: Exento R.D. 635/2015

Contact:   contacto@jnnpr.com

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

The journal does not charge fees for job submission, no fees for the publication of their articles.